For people with depression that hasn’t responded to other treatments, using a nasal spray called esketamine for six months may significantly help lift their mood, based on standard depression scores.
Claim Language
Language Strength
association
Uses association language (linked to, correlated with)
The claim uses 'is associated with' and 'suggesting potential for', which indicate a relationship or correlation rather than a direct cause or certainty. These phrases avoid claiming causation or definitive outcomes.
Context Details
Domain
medicine
Population
human
Subject
Adults with treatment-resistant depression
Action
is associated with
Target
a clinically meaningful reduction in depressive symptoms, as measured by the MADRS (mean decrease of 19.5 points) and BDI-II (mean decrease of 19.3 points)
Intervention Details
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Evidence from Studies
Supporting (1)
This study gave people with severe depression that didn’t respond to other treatments a nasal spray called esketamine for six months, and their depression got much better — just like the claim says.